	Israel Securities Authority			Tel Aviv Stock Exchange		C001 ( Public )		Reported via MAGNA:	28/07/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-077476	Time of broadcast: 06:40 06:38:18

Report of Periodic or Interim Report

Regulation 3 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Q2-2019

6K_Q22019_isa.pdf

Link of EDGAR Filing: https://www.sec.gov/Archives/edgar/data/1596812/000121390019013728/0001213900-19-013728-index.htm


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: -1	Date of revision of form structure: 25/06/2019
Address: Einstein 14 , NES-ZIONA 7403618 , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: shachar@enlivexpharm.com Company site: www.enlivex.com

Previous names of reporting entity:

Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D
Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: shachar@ramdor.co.il 2
ISRAEL